Paroxetine in the treatment of generalised anxiety disorder.

Published

Journal Article (Review)

Paroxetine is a selective serotonin re-uptake inhibitor useful in the treatment of a wide range of psychiatric disorders. Generalised anxiety disorder (GAD) is characterised by excessive persistent anxiety and worry about a number of events and activities occurring on more days than not for at least 6 months. GAD is the most common anxiety disorder in primary care settings. Paroxetine was the second antidepressant to receive an FDA indication for the treatment of GAD. In contrast to benzodiazepines, which had been the mainstay of treatment for anxiety disorders for many years, antidepressants, such as paroxetine, are more effective for the psychic symptoms of anxiety, which include worry, tension, irritability and concentration difficulties, and carry a more tolerable and safe side effect profile.

Full Text

Duke Authors

Cited Authors

  • Snyderman, SH; Rynn, MA; Bellew, K; Rickels, K

Published Date

  • August 2004

Published In

Volume / Issue

  • 5 / 8

Start / End Page

  • 1799 - 1806

PubMed ID

  • 15264994

Pubmed Central ID

  • 15264994

Electronic International Standard Serial Number (EISSN)

  • 1744-7666

Digital Object Identifier (DOI)

  • 10.1517/14656566.5.8.1799

Language

  • eng

Conference Location

  • England